Rozporządzenie Komisji (WE) nr 790/2009 z dnia 10 sierpnia 2009 r. dostosowujące do postępu naukowo-technicznego rozporządzenie Parlamentu Europejskiego i Rady (WE) nr 1272/2008 z dnia 16 grudnia 2008 r. w sprawie klasyfikacji, oznakowania i pakowania substancji i mieszanin
Załącznik II
W mocyNumer indeksowy
Międzynarodowa terminologia chemiczna
Numer WE
Numer CAS
Klasyfikacja
Oznakowanie
Specyficzne stężenia graniczne i współczynniki „M”
Uwagi
Klasa zagrożenia i kody kategorii
Kody zwrotów wskazujących rodzaj zagrożenia
Piktogram, kody haseł ostrzegawczych
Kody zwrotów wskazujących rodzaj zagrożenia
Dodatkowe kody zwrotów wskazujących rodzaj zagrożenia
003-003-00-5
(2-methylpropyl)lithium;
isobutyllithium
440-620-2
920-36-5
Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H314
H336
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H260
H250
H314
H336
H410
EUH014
005-007-00-2
boric acid; [1]
boric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]
233-139-2 [1]
234-343-4 [2]
10043-35-3 [1]
11113-50-1 [2]
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr. 1B; H360FD: C ≥ 5,5 %
005-008-00-8
diboron trioxide;
boric oxide
215-125-8
1303-86-2
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr. 1B; H360FD: C ≥ 3,1 %
005-011-00-4
disodium tetraborate, anhydrous;
boric acid, disodium salt; [1]
tetraboron disodium heptaoxide, hydrate; [2]
orthoboric acid, sodium salt [3]
215-540-4 [1]
235-541-3 [2]
237-560-2 [3]
1330-43-4 [1]
12267-73-1 [2]
13840-56-7 [3]
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr. 1B; H360FD: C ≥ 4,5 %
005-011-01-1
disodium tetraborate decahydrate;
borax decahydrate
215-540-4
1303-96-4
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr. 1B; H360FD: C ≥ 8,5 %
005-011-02-9
disodium tetraborate pentahydrate;
borax pentahydrate
215-540-4
12179-04-3
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr. 1B; H360FD: C ≥ 6,5 %
005-013-00-5
diethylmethoxyborane
425-380-9
7397-46-8
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H250
H332
H312
H302
H373**
H314
H317
H413
GHS02
GHS05
GHS08
GHS07
Dgr
H250
H332
H312
H302
H373**
H314
H317
H413
005-014-00-0
4-formylphenylboronic acid
438-670-5
87199-17-5
Skin Sens. 1
H317
GHS07
Wng
H317
005-015-00-6
1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
414-380-4
140681-55-6
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
005-016-00-1
tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate
431-370-5
— Aquatic Chronic 4
H413
— H413
005-017-00-7
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Oxid. Sol. 2
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-017-01-4
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Oxid. Sol. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-018-00-2
perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
STOT SE 3
Eye Dam. 1
H360Df
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H335
H318
Repr. 1B; H360 Df: C ≥ 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C ≥ 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-018-01-X
perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H360Df
H332
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H332
H335
H318
Repr. 1B; H360 Df: C ≥ 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C ≥ 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-019-00-8
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Oxid. Sol. 3
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-019-01-5
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Oxid. Sol. 3
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
006-091-00-3
propineb (ISO);
polymeric zinc propylenebis(dithiocarbamate)
— 9016-72-2
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H332
H373**
H317
H400
GHS08
GHS07
GHS09
Wng
H332
H373**
H317
H400
006-092-00-9
tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate
425-420-5
98737-29-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
006-093-00-4
2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)
427-180-7
— Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
006-094-00-X
O-isobutyl-N-ethoxy carbonylthiocarbamate
434-350-4
103122-66-3
Flam. Liq. 3
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H226
H350
H340
H302
H373**
H317
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H350
H340
H302
H373**
H317
H411
006-095-00-5
fosetyl-aluminium (ISO);
aluminium triethyl triphosphonate
254-320-2
39148-24-8
Eye Dam. 1
H318
GHS05
Dgr
H318
006-096-00-0
chlorpropham (ISO);
isopropyl 3-chlorocarbanilate
202-925-7
101-21-3
Carc. 2
STOT RE 2 *
Aquatic Chronic 2
H351
H373**
H411
GHS08
GHS09
Wng
H351
H373**
H411
006-097-00-6
1-phenyl-3-(p-toluenesulfonyl)urea
424-620-1
13909-63-2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
006-098-00-1
tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
429-170-8
134575-17-0
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgrg
H302
H373**
H318
H317
006-099-00-7
N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate
432-520-2
232938-43-1
Aquatic Chronic 2
H411
GHS09
H411
006-101-00-6
reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;
N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]
423-070-8
— Aquatic Chronic 4
H413
— H413
006-102-00-1
O-hexyl-N-ethoxycarbonylthiocarbamate
432-750-3
— Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H340
H302
H373**
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H340
H302
H373**
H317
H411
006-103-00-7
N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea
445-760-8
— Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H334
H400
H410
GHS05
GHS08
GHS09
Dgr
H318
H334
H410
M=100
007-028-00-2
hydroxylammonium nitrate
236-691-2
13465-08-2
Expl. 1.1 ****
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H311
H302
H373**
H319
H315
H317
H400
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H351
H311
H302
H373**
H319
H315
H317
H400
007-029-00-8
diethyldimethylammonium hydroxide
419-400-5
95500-19-9
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
012-004-00-X
aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate
422-150-1
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
013-010-00-5
hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)
430-650-4
151841-65-5
Aquatic Chronic 2
H411
GHS09
H411
014-033-00-3
2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica
419-030-4
125804-20-8
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
014-034-00-9
3-hexylheptamethyltrisiloxane
428-700-5
1873-90-1
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
014-035-00-4
2-(3,4-epoxycyclohexyl)ethyltriethoxy silane
425-050-4
10217-34-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
014-036-00-X
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane
405-020-7
105024-66-6
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F***
H400
H410
GHS08
GHS09
Dgr
H360F***
H410
M=1000
014-037-00-5
2-butanone-O,O',O''-(phenylsilylidyne)trioxime
433-360-6
34036-80-1
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373**
H317
H412
GHS08
GHS07
Wng
H373**
H317
H412
014-038-00-0
S-(3-(triethoxysilyl)propyl) octanethioate
436-690-9
220727-26-4
Skin Sens. 1
H317
GHS07
Wng
H317
014-039-00-6
(2,3-dimethylbut-2-yl)-trimethoxysilane
439-360-2
142877-45-0
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
014-041-00-7
N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane
445-890-5
201290-01-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
014-042-00-2
reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-010-0
— Eye Dam. 1
H318
GHS05
Dgr
H318
014-043-00-8
reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)
432-200-2
— Aquatic Chronic 2
H411
GHS09
H411
014-044-00-3
3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane
433-050-0
— Aquatic Chronic 2
H411
GHS09
H411
014-045-00-9
magnesium sodium fluoride silicate
442-650-1
— STOT RE 2 *
H373**
GHS08
Wng
H373**
015-113-00-0
tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate
260-515-3
57018-04-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
015-182-00-7
tetraisopropyldichloromethylenebisphosphonate
430-630-5
10596-22-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS06
Wng
H302
H319
H317
015-183-00-2
(1-hydroxydodecylidene)diphosphonic acid
425-230-2
16610-63-2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
015-188-00-X
(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate
425-220-8
5945-33-5
Aquatic Chronic 4
H413
— H413
015-190-00-0
bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
421-920-2
154862-43-8
Aquatic Chronic 4
H413
— H413
015-191-00-6
dodecyldiphenyl phosphate
431-760-5
27460-02-2
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
015-192-00-1
tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate
432-770-2
139189-30-3
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
015-193-00-7
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)
442-960-7
332350-93-3
Acute Tox. 3 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H400
H410
GHS05
GHS06
GHS09
Dgr
H301
H318
H410
015-194-00-2
tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate
444-440-5
220689-12-3
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
015-195-00-8
reaction mass of: potassium o-toluenephosphonate;
potassium m-toluenephosphonate;
potassium p-toluenephosphonate
433-860-4
— Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
015-196-00-3
reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
435-960-3
— Carc. 1B
Muta. 1B
Skin Sens. 1
H350
H340
H317
GHS08
GHS07
Dgr
H350
H340
H317
015-197-00-9
bis(2,4,4-trimethylpentyl)dithiophosphonic acid
420-160-9
107667-02-7
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H226
H331
H302
H314
H411
GHS02
GHS06
GHS05
GHS09
Dgr
H226
H331
H302
H314
H411
015-198-00-4
(4-phenylbutyl)phosphinic acid
420-450-5
86552-32-1
Carc. 2
Eye Dam. 1
H351
H318
GHS05
GHS08
Dgr
H351
H318
016-092-00-0
reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol
427-050-1
— Repr. 1A
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H361f
H315
H317
H410
016-094-00-1
sulfur
231-722-6
7704-34-9
Skin Irrit. 2
H315
GHS07
Wng
H315
016-097-00-8
1-amino-2-methyl-2-propanethiol hydrochloride
434-480-1
32047-53-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H302
H314
H317
H412
GHS05
GHS07
Dgr
H302
H314
H317
H412
017-023-00-7
[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides
425-520-9
197179-61-6
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
022-004-00-1
potassium titanium oxide (K2Ti6O13)
432-240-0
12056-51-8
Carc. 2
H351
GHS08
Dgr
H351
022-005-00-7
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium
419-840-8
169104-71-6
Flam. Sol. 1****
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H228
H314
H317
H413
GHS02
GHS05
GHS07
Dgr
H228
H314
H317
H413
024-021-00-X
potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)
425-830-4
— Eye Dam. 1
H318
GHS05
Dgr
H318
026-003-00-7
iron (II) sulfate
231-753-5
7720-78-7
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
026-003-01-4
iron (II) sulfate (1:1) heptahydrate;
sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate
231-753-5
7782-63-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
Skin Irrit. 2; H315: C ≥ 25 %
026-004-00-2
potassium ferrite
430-010-4
12160-44-0
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
027-006-00-6
cobalt acetate
200-755-8
71-48-7
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M=10
1
027-007-00-1
zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex
425-240-7
— Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
027-008-00-7
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O,2<n<3)
427-390-9
— Skin Sens. 1
H317
GHS07
Wng
H317
027-009-00-2
cobalt nitrate
233-402-1
10141-05-6
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M=10
1
027-010-00-8
cobalt carbonate
208-169-4
513-79-1
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M=10
1
028-002-01-4
nickel powder;
[particle diameter < 1 mm]
231-111-4
7440-02-0
Carc. 2
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H351
H372**
H317
H412
GHS08
GHS07
Dgr
H351
H372**
H317
H412
028-011-00-6
nickel dichloride
231-743-0
7718-54-9
Carc. 1A
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H410
STOT RE. 1; H373: C ≥ 1 %
STOT RE. 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-012-00-1
nickel dinitrate; [1]
nitric acid, nickel salt [2]
236-068-5 [1]
238-076-4 [2]
13138-45-9 [1]
14216-75-2 [2]
Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350i
H341
H360D***
H372**
H332
H302
H318
H315
H317
H400
H410
GHS03
GHS05
GHS08
GHS07
GHS09
Dgr
H272
H350i
H341
H360D***
H372**
H332
H302
H318
H315
H317
H410
STOT RE. 1; H373: C ≥ 1 %
STOT RE. 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-013-00-7
nickel matte
273-749-6
69012-50-6
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-014-00-2
slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate
295-859-3
92129-57-2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-015-00-8
slimes and sludges, copper electrolyte refining, decopperised
305-433-1
94551-87-8
Carc. 1A
Muta. 2
Repr. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
H
028-016-00-3
nickel diperchlorate;
perchloric acid, nickel(II) salt
237-124-1
13637-71-3
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H314
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-017-00-9
nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]
237-563-9 [1]
239-793-2 [2]
13842-46-1 [1]
15699-18-0 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-018-00-4
nickel bis(sulfamidate);
nickel sulfamate
237-396-1
13770-89-3
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-019-00-X
nickel bis(tetrafluoroborate)
238-753-4
14708-14-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-021-00-0
nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]
222-101-0 [1]
239-946-6 [2]
268-755-0 [3]
3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-022-00-6
nickel di(acetate); [1]
nickel acetate [2]
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
E H
028-024-00-7
nickel dibenzoate
209-046-8
553-71-9
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-025-00-2
nickel bis(4-cyclohexylbutyrate)
223-463-2
3906-55-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-026-00-8
nickel(II) stearate;
nickel(II) octadecanoate
218-744-1
2223-95-2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-027-00-3
nickel dilactate
— 16039-61-5
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-028-00-9
nickel(II) octanoate
225-656-7
4995-91-9
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H314
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-029-00-4
nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]
233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]
10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-030-00-X
nickel hexafluorosilicate
247-430-7
26043-11-8
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-031-00-5
nickel selenate
239-125-2
15060-62-5
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-032-00-0
nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]
238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]
14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H
028-033-00-6
diammonium nickel hexacyanoferrate
— 74195-78-1
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H
028-034-00-1
nickel dicyanide
209-160-8
557-19-7
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
EUH032
H
028-035-00-7
nickel chromate
238-766-5
14721-18-7
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H
028-036-00-2
nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]
21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-037-00-8
dinickel hexacyanoferrate
238-946-3
14874-78-3
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-038-00-3
trinickel bis(arsenate);
nickel(II) arsenate
236-771-7
13477-70-8
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H372**
H317
H410
H
028-039-00-9
nickel oxalate; [1]
oxalic acid, nickel salt [2]
208-933-7 [1]
243-867-2 [2]
547-67-1 [1]
20543-06-0 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-040-00-4
nickel telluride
235-260-6
12142-88-0
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-041-00-X
trinickel tetrasulfide
— 12137-12-1
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-042-00-5
trinickel bis(arsenite)
— 74646-29-0
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-043-00-0
cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]
269-051-6 [1]
261-346-8 [2]
- [3]
68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H
028-044-00-6
nickel tin trioxide;
nickel stannate
234-824-9
12035-38-0
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H
028-045-00-1
nickel triuranium decaoxide
239-876-6
15780-33-3
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H
028-046-00-7
nickel dithiocyanate
237-205-1
13689-92-4
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
EUH032
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-047-00-2
nickel dichromate
239-646-5
15586-38-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-048-00-8
nickel(II) selenite
233-263-7
10101-96-9
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H
028-049-00-3
nickel selenide
215-216-2
1314-05-2
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-050-00-9
silicic acid, lead nickel salt
— 68130-19-8
Carc. 1A
Repr. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360Df
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H360Df
H372**
H317
H410
H
028-051-00-4
nickel diarsenide; [1]
nickel arsenide [2]
235-103-1 [1]
248-169-1 [2]
12068-61-0 [1]
27016-75-7 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-052-00-X
nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900
271-853-6
68610-24-2
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H
028-053-00-5
nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]
267-897-0 [1]
238-596-1 [2]
275-897-7 [3]
67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %1
M=1
H
028-054-00-0
nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O
1,O
2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids,C6-19-branched, nickel salts; [29]
fatty acids,C8-18 and C18-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]
240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]
16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H
028-055-00-6
nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]
231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]
7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H
028-056-00-1
nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]
234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]
12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H
028-057-00-7
dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]
234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]
12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H
028-058-00-2
cobalt lithium nickel oxide
442-750-5
— Carc. 1A
Acute Tox. 2 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H330
H372**
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H330
H372**
H317
H410
029-014-00-5
reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex;
2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex
419-610-7
171866-24-3
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411
030-009-00-5
zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate
417-130-2
— Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
030-010-00-0
2-dodec-1-enylbutanedioic acid,4-methyl ester zinc salt
430-740-3
— Aquatic Chronic 2
H411
GHS09
H411
030-012-00-1
aluminium-magnesium-zinc-carbonate-hydroxide
423-570-6
169314-88-9
Aquatic Chronic 3
H412
— H412
030-015-00-8
tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate
440-060-9
— Aquatic Chronic 2
H411
GHS09
H411
040-003-00-4
reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1.0: 1.0 to 1.0: 1.5
430-610-6
226996-19-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
042-005-00-0
reaction mass of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate molybdenum complex
434-240-6
— Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
046-001-00-X
tetraammine palladium (II) hydrogen carbonate
425-270-0
134620-00-1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373**
H318
H317
H410
047-002-00-8
polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt
416-850-4
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
050-021-00-4
dichlorodioctyl stannane
222-583-2
3542-36-7
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
H331
H372**
H412
GHS06
GHS08
Dgr
H331
H372**
H412
050-022-00-X
dibutyltin dichloride;
(DBTC)
211-670-0
683-18-1
Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H360FD
H330
H301
H312
H372**
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H360FD
H330
H301
H312
H372**
H314
H410
Skin Corr. 1B; H314: C ≥ 5 %
Skin Irrit. 2; H315: 0,01 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,01 % ≤ C < 3 %
M=10
050-023-00-5
reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane
422-920-5
— STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
M=10
050-024-00-0
reaction mass of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane
432-230-6
— STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H372**
H302
H315
H318
H317
H410
064-001-00-8
gadolinium(III)sulfite trihydrate
456-900-2
51285-81-5
Aquatic Chronic 2
H411
GHS09
H411
078-010-00-X
tetraammine platinum (II) hydrogen carbonate
426-730-3
123439-82-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
078-011-00-5
hydroxydisulfito platinum(II) acid
423-310-1
61420-92-6
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373
H314
H334
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373
H314
H334
H317
H412
078-012-00-0
platinum(IV) nitrate/nitric acid solution
432-400-1
— Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
082-012-00-6
barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped
431-780-4
199876-46-5
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373**
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H411
601-070-00-0
reaction mass of: branched icosane;
branched docosane;
branched tetracosane
417-050-8
151006-58-5
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
601-072-00-1
reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;
1-(3-isopropylphenyl)-1-phenylethane;
1-(2-isopropylphenyl)-1-phenylethane
430-690-2
52783-21-8
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
601-075-00-8
4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane
418-770-5
151882-81-4
Carc. 2
H351
GHS08
Wng
H351
601-076-00-3
ethynyl cyclopropane
425-430-1
6746-94-7
Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H225
H315
H318
H412
GHS02
GHS05
Dgr
H225
H315
H318
H412
601-077-00-9
reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;
1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane
426-510-7
196965-91-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
601-078-00-4
reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;
2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane
427-040-5
— Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
601-079-00-X
reaction mass of: trans-trans-cyclohexadeca-1,9-diene;
cis-trans-cyclohexadeca-1,9-diene
429-620-3
— Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
601-080-00-5
reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers
431-100-6
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
601-081-00-0
cyclohexadeca-1,9-diene
431-730-1
4277-06-9
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
601-082-00-6
reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane
434-420-4
— Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
601-083-00-1
5-endo-hexyl-bicyclo[2.2.1]hept-2-ene
435-000-3
22094-83-3
Asp. Tox. 1
Skin Irrit. 2
Aquatic Chronic 4
H304
H315
H413
GHS08
GHS07
Dgr
H304
H315
H413
601-084-00-7
reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)
435-180-3
— Asp. Tox. 1
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H304
H315
H400
H410
GHS08
GHS07
GHS09
Dgr
H304
H315
H410
602-095-00-X
alkanes,C14-17, chloro;
chlorinated paraffins,C14-17
287-477-0
85535-85-9
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
H410
EUH066
602-098-00-6
2-(3-bromophenoxy)tetrahydro-2H-pyran
429-030-6
57999-49-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
602-099-00-1
3-(4-fluorophenyl)-2-methylpropionylchloride
426-370-7
— Skin Corr. 1A
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412
EUH014
EUH029
602-100-00-5
reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;
(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane
420-640-8
— Aquatic Chronic 3
H412
— H412
602-101-00-0
2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate
427-020-6
141772-37-4
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373**
H317
H410
602-102-00-6
1,1,1,3,3-pentafluorobutane
430-250-1
406-58-6
Flam. Liq. 2
H225
GHS02
Dgr
H225
602-103-00-1
1-(chlorophenylmethyl)-2-methylbenzene
431-450-1
41870-52-4
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
602-104-00-7
1,1,2,2,3,3,4-heptafluorocyclopentane
430-710-1
15290-77-4
Aquatic Chronic 3
H412
— H412
602-105-00-2
sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate
422-100-7
102061-82-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
602-106-00-8
2-bromo-4,6-difluoroaniline
429-430-0
444-14-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
602-107-00-3
3,3,4,4-tetrafluoro-4-iodo-1-butene
439-500-2
33831-83-3
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H302
H315
H411
GHS07
GHS09
Wng
H302
H315
H411
602-108-00-9
(2,3,5,6-tetrafluorophenyl)methanol
443-840-7
4084-38-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
603-109-00-7
reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;
1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane
425-340-0
— Aquatic Chronic 4
H413
— H413
603-110-00-2
reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;
trans-2-isobutyl-5-methyl 1,3-dioxane
426-130-1
166301-21-9
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
603-111-00-8
reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;
1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane
426-530-6
— Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
603-112-00-3
cyclopentyl 2-phenylethyl ether
428-340-9
— Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
603-113-00-9
6-glycidyloxynapht-1-yl oxymethyloxirane
429-960-2
27610-48-6
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H341
H312
H315
H317
H412
GHS08
GHS07
Wng
H341
H312
H315
H317
H412
603-114-00-4
9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene
430-830-2
26912-64-1
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-115-00-X
reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-580-0
— STOT RE 2 *
Aquatic Chronic 4
H373**
H413
GHS08
Wng
H373**
H413
603-116-00-5
(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride
424-740-2
138271-16-6
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
603-182-00-5
reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide
428-630-5
— Skin Sens. 1
H317
GHS07
Wng
H317
603-188-00-8
reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;
7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene
426-970-9
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-190-00-9
8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane
424-030-2
62406-73-9
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
603-192-00-X
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol
423-240-1
125474-34-2
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
603-193-00-5
disodium 9,10-anthracenedioxide
426-030-8
46492-07-3
Skin Corr. 1A
H314
GHS05
Dgr
H314
603-194-00-0
2-(2-aminoethylamino)ethanol;
(AEEA)
203-867-5
111-41-1
Repr. 1B
Skin Corr. 1B
Skin Sens. 1
H360Fd
H361
H314
H317
GHS05
GHS08
GHS07
Dgr
H360Fd
H361
H314
H317
STOT SE 3; H335: C ≥ 5 %
603-200-00-1
1-pentanol; [1]
3-pentanol [2]
200-752-1 [1]
209-526-7 [2]
71-41-0 [1]
584-02-1 [2]
Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H226
H332
H335
H315
GHS02
GHS07
Wng
H226
H332
H335
H315
603-201-00-7
(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol
416-120-5
— Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413
603-202-00-2
4,4,5,5,5-pentafluoropentan-1-ol
421-360-9
148043-73-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-203-00-8
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane
427-580-1
— Skin Irrit. 2
H315
GHS07
Wng
H315
603-204-00-3
reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;
2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane
428-110-8
— Aquatic Chronic 3
H412
— H412
603-205-00-9
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride
426-200-1
172015-79-1
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H372**
H302
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H372**
H302
H318
H317
H412
603-206-00-4
2,2-dichloro-1,3-benzodioxol
426-850-6
2032-75-9
Flam. Liq. 3
Skin Corr. 1A
Acute Tox. 4 *
Skin Sens. 1
H226
H314
H302
H317
GHS02
GHS05
GHS07
Dgr
H226
H314
H302
H317
EUH014
603-207-00-X
2-isobutyl-2-isopropyl-1,3-dimethoxypropane
430-800-9
129228-21-3
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-208-00-5
1,2-diethoxyethane
211-076-1
629-14-1
Flam. Liq. 2
Repr. 1A
Eye Irrit. 2
H225
H360Df
H319
GHS02
GHS08
GHS07
Dgr
H225
H360Df
H319
EUH019
603-209-00-0
spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);
reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]
spinosyn A; [2]
spinosyn D [3]
- [1]
- [2]
- [3]
- [1]
131929-60-7 [2]
131929-63-0 [3]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=10
603-210-00-6
2,4-diethyl-1,5-pentanediol
429-310-8
57987-55-0
Eye Dam. 1
H318
GHS05
Dgr
H318
603-211-00-1
2,3-epoxypropyltrimethylammonium chloride … %;
glycidyl trimethylammonium chloride … %
221-221-0
3033-77-0
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H361f***
H312
H302
H373**
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H350
H341
H361f***
H312
H302
H373**
H318
H317
H412
B
603-212-00-7
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
galaxolide;
(HHCB)
214-946-9
1222-05-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-213-00-2
2-methoxy-2-methylbutane;
tert-amyl methyl ether
213-611-4
994-05-8
Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
H225
H302
H336
GHS02
GHS07
Dgr
H225
H302
H336
603-214-00-8
1,1-diisopropoxycyclohexane
413-740-8
1132-95-2
Skin Corr. 1B
H314
GHS05
Dgr
H314
603-215-00-3
1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
418-330-2
162241-33-0
Expl. 1.1****
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H302
H373**
H318
H317
H400
H410
GHS01
GHS05
GHS08
GHS07
GHS09
Dgr
H201
H302
H373**
H318
H317
H410
603-216-00-9
cis-1-amino-2,3-dihydro-1H-inden-2-ol
422-660-2
7480-35-5
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
603-217-00-4
2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite
423-560-1
161717-32-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
603-220-00-0
1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol
432-890-5
72955-94-3
Aquatic Chronic 4
H413
— H413
603-221-00-6
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
603-221-01-3
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H350
H302
H314
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H350
H302
H314
H411
603-222-00-1
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
433-820-6
118058-74-5
Eye Irrit. 2
H319
GHS07
Wng
H319
603-223-00-7
2-cyclopentylidene cyclopentanol;
1,1'-bi(cyclopentyliden)-2-ol
434-270-1
6261-30-9
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
603-224-00-2
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane
435-790-1
297730-93-9
Aquatic Chronic 4
H413
— H413
603-225-00-8
erythromycin A9-oxime (E);
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
437-070-0
13127-18-9
Aquatic Chronic 2
H411
GHS09
H411
603-226-00-3
4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol
444-500-0
1440-00-2
Aquatic Chronic 3
H412
— H412
603-227-00-9
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate
445-060-2
203574-04-3
****
Aquatic Acute 1
Aquatic Chronic 1
****
H400
H410
****
GHS09
Wng
****
H410
603-228-00-4
(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane
419-620-1
— Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
603-229-00-X
sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate
420-800-7
— Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
603-230-00-5
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan
440-030-5
— Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 4
H315
H318
H413
GHS05
Dgr
H315
H318
H413
603-231-00-0
(S)-1,1-diphenyl-1,2-propanediol
443-220-6
— Aquatic Chronic 3
H412
— H412
603-232-00-6
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane
444-420-6
— Aquatic Chronic 4
H413
— H413
603-233-00-1
reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol
444-430-0
— Aquatic Chronic 2
H411
GHS09
H411
603-234-00-7
(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene
444-480-3
— Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
604-071-00-4
4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol
425-600-3
110726-28-8
Aquatic Chronic 4
H413
— H413
604-072-00-X
1,2-bis(phenoxymethyl)benzene
428-620-0
10403-74-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-073-00-5
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
428-010-4
82413-20-5
Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H360F***
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H351
H360F***
H317
H410
604-074-00-0
tetrabromobisphenol-A;
2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol
201-236-9
79-94-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-075-00-6
4-(1,1,3,3-tetramethylbutyl)phenol;
4-tert-octylphenol
205-426-2
140-66-9
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
M=10
604-076-00-1
phenolphthalein
201-004-7
77-09-8
Carc. 1B
Muta. 2
Repr. 2
H350
H341
H361f***
GHS08
Dgr
H350
H341
H361f***
Carc. 1A; H350: C ≥ 1 %
604-077-00-7
2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol
419-750-9
98809-58-6
Aquatic Chronic 4
H413
— H413
604-079-00-8
4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol
428-970-4
13595-25-0
Repr. 2
Skin Sens. 1
Aquatic Chronic 2
H361f***
H317
H411
GHS08
GHS09
Wng
H361f***
H317
H411
604-080-00-3
4-fluoro-3-trifluoromethylphenol
432-560-0
61721-07-1
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Chronic 2
H332
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H332
H314
H317
H411
604-081-00-9
1,1-bis(4-hydroxyphenyl)-1-phenylethane
433-130-5
1571-75-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-082-00-4
2-chloro-6-fluoro-phenol
433-890-8
2040-90-6
Muta. 1B
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H340
H361f***
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H340
H361f***
H302
H314
H317
H411
604-083-00-X
4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol
439-270-3
260408-02-4
Aquatic Chronic 4
H413
— H413
604-084-00-5
1-ethoxy-2,3-difluorobenzene
441-000-4
121219-07-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
604-087-00-1
reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol
433-640-8
— Pyr. Sol. 1
Aquatic Chronic 4
H250
H413
GHS02
Dgr
H250
H413
EUH044
604-089-00-2
2-methyl-5-tert-butylthiophenol
444-970-7
— Flam. Liq. 3
Repr. 2
STOT RE 2 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H226
H361d***
H373**
H304
H319
H315
H317
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H361d***
H373**
H304
H319
H315
H317
H336
H410
605-023-00-5
5-chloro-2-(4-chlorophenoxy)phenol
429-290-0
3380-30-1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
605-024-00-0
2-bromo-5-hydroxy-4-methoxybenzaldehyde
426-540-0
2973-59-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-032-00-4
3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal
425-370-4
93957-50-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
605-033-00-X
reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;
3,7,11-trimethyl-trans-6,10-dodecadienal
425-910-9
32480-08-3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
605-034-00-5
reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde
429-860-9
— Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-035-00-0
(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal
426-330-9
177964-68-0
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H319
H317
H413
GHS07
Wng
H319
H317
H413
605-036-00-6
2-bromomalonaldehyde
430-470-6
2065-75-0
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
605-037-00-1
trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde
421-800-1
120578-03-2
Aquatic Chronic 4
H413
— H413
605-038-00-7
3-methyl-5-phenylpentan-1-al
433-900-0
55066-49-4
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H315
H317
H411
GHS07
GHS09
Wng
H302
H315
H317
H411
605-039-00-2
3,4-dihydroxy-5-nitrobenzaldehyde
441-810-8
116313-85-0
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
606-074-00-6
reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;
(2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene
425-570-1
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-090-00-3
1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone
430-920-1
73096-98-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
606-093-00-X
5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one
414-470-3
95885-13-5
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
606-094-00-5
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one
417-460-7
— Aquatic Chronic 4
H413
— H413
606-095-00-0
(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one
421-830-3
49805-30-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
606-096-00-6
3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
424-170-4
130603-71-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
606-097-00-1
2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone
424-210-0
23911-85-5
Aquatic Chronic 4
H413
— H413
606-098-00-7
1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione
431-220-9
158574-65-3
Aquatic Chronic 4
H413
— H413
606-099-00-2
5-methoxy-4'-(trifluoromethyl)valerophenone
425-000-1
61718-80-7
Aquatic Chronic 2
H411
GHS09
H411
606-100-00-6
2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one
425-150-8
94723-86-1
Repr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H360F***
H302
H317
H412
GHS08
GHS07
Dgr
H360F***
H302
H317
H412
606-101-00-1
reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;
1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;
1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione
426-050-7
165038-51-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-102-00-7
4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone
431-490-8
79876-59-8
Aquatic Chronic 2
H411
GHS09
H411
606-103-00-2
1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone
426-460-6
— Skin Sens. 1
H317
GHS07
Wng
H317
606-104-00-8
1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone
426-830-7
78531-59-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-105-00-3
3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione
431-500-0
226065-73-2
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-106-00-9
1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone
427-320-7
83626-30-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-107-00-4
8-azaspiro[4.5]decane-7,9-dione
427-770-4
1075-89-4
Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411
606-108-00-X
1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone
436-710-6
756-13-8
Aquatic Chronic 3
H412
— H412
606-109-00-5
2-(4-methyl-3-pentenyl)anthraquinone
428-320-1
71308-16-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4
H302
H317
H314
GHS07
Wng
H302
H317
H314
606-110-00-0
5-ethoxy-5H-furan-2-one
428-330-4
2833-30-9
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
H314
H312
H302
H373**
H317
GHS05
GHS08
GHS07
Dgr
H314
H312
H302
H373**
H317
606-111-00-6
5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one
428-410-9
67014-36-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
606-112-00-1
(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one
428-690-2
1668-86-6
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412
606-113-00-7
1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one
429-040-0
272460-97-6
Eye Dam. 1
Aquatic Chronic 4
H318
H314
GHS05
Dgr
H318
H314
606-114-00-2
4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone
429-150-9
67887-47-2
Aquatic Chronic 4
H413
— H413
606-115-00-8
profoxydim (ISO);
2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
— 139001-49-3
Carc. 2
Repr. 2
Skin Sens. 1
H351
H361d
H317
GHS08
GHS07
Wng
H351
H361d
H317
606-116-00-3
tepraloxydim (ISO);
(RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
— 149979-41-9
Carc. 2
Repr. 2
H351
H361fd
GHS08
Wng
H351
H361fd
606-117-00-9
2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one
429-460-4
7078-98-0
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-118-00-4
N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine
429-640-2
52870-46-9
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
606-119-00-X
(E)-3-methyl-5-cyclopentadecen-1-one
429-900-5
— Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
606-120-00-5
2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one
430-170-5
114625-74-0
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
606-121-00-0
(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)
430-460-1
133636-82-5
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
606-122-00-6
3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one
430-820-8
114341-88-7
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373**
H315
H318
H317
H410
606-123-00-1
4-hexadecyl-1-phenylpyrazolidin-3-one
430-840-7
— Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-124-00-7
1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione
421-080-7
161462-35-7
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
606-125-00-2
1-benzylimidazolidine-2,4-dione
421-340-1
6777-05-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
606-126-00-8
1,4-bis(2,3-dihydroxypropylamino)anthraquinone
421-470-7
99788-75-7
Aquatic Chronic 2
H411
GHS09
H411
606-128-00-9
2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione
422-650-8
148935-94-8
Aquatic Chronic 4
H413
— H413
606-129-00-4
5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
423-090-7
156732-13-7
Aquatic Chronic 4
H413
— H413
606-130-00-X
4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone
423-860-2
56309-94-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-131-00-5
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
427-230-8
5571-36-8
Repr. 1B
STOT RE 2 *
Aquatic Chronic 2
H360F***
H373**
H411
GHS08
GHS09
Dgr
H360F***
H373**
H411
606-132-00-0
(6β)-6,19-epoxyandrost-4-ene-3,17-dione
433-490-3
6563-83-3
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-134-00-1
androsta-1,4,9(11)-triene-3,17-dione
433-560-3
15375-21-0
Repr. 2
H361f***
GHS08
Wng
H361f***
606-135-00-7
cyclohexadecanone
438-930-8
2550-52-9
Aquatic Chronic 4
H413
— H413
606-136-00-2
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone
444-350-6
133413-70-4
Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413
606-137-00-8
trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione
444-750-0
211387-26-7
Aquatic Chronic 4
H413
— H413
606-138-00-3
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone
444-800-1
141645-23-0
Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373**
H315
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H226
H302
H373**
H315
H318
H317
H410
M=10
606-139-00-9
(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one
444-830-5
124379-29-9
Aquatic Chronic 4
H413
— H413
606-140-00-4
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one
444-860-9
474510-57-1
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
606-141-00-X
sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate
418-410-7
— Eye Irrit. 2
H319
GHS07
Wng
H319
606-142-00-5
reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one
434-290-9
— Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-417-00-2
3-chloropropyl chloroformiate
425-770-9
628-11-5
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H331
H302
H373**
H315
H318
H317
GHS06
GHS05
GHS08
Dgr
H331
H302
H373**
H315
H318
H317
607-428-00-2
tetrasodium ethylene diamine tetraacetate
200-573-9
64-02-8
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
607-429-00-8
edetic acid;
(EDTA)
200-449-4
60-00-4
Eye Irrit. 2
H319
GHS07
Wng
H319
607-471-00-7
1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane
429-280-6
151900-44-6
Aquatic Chronic 4
H413
— H413
607-473-00-8
pentaerythritol, dipentaerythritol, fatty acids,C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid
426-590-3
187412-41-5
Skin Sens. 1
H317
GHS07
Wng
H317
607-477-00-X
(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt
426-740-8
— Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
607-481-00-1
reaction mass of: trihexyl citrate;
dihexyloctyl citrate;
dioctylhexyl citrate;
dihexyldecyl citrate
430-290-8
— Aquatic Chronic 4
H413
— H413
607-482-00-7
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride
430-360-8
84793-24-8
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-483-00-2
1,2-benzenedicarboxylic acid;
di-C6-8-branched alkylesters,C7-rich
276-158-1
71888-89-6
Repr. 1B
H360D***
GHS08
Dgr
H360D***
607-484-00-8
ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionate
430-480-0
221452-67-1
Aquatic Chronic 4
H413
— H413
607-485-00-3
(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate
430-510-2
— Aquatic Chronic 4
H413
— H413
607-486-00-9
potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate
402-110-8
110081-40-8
Aquatic Chronic 3
H412
— H412
607-491-00-6
reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);
triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)
427-140-9
— Carc. 2
H351
GHS08
Wng
H351
607-504-00-5
diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate
422-670-7
— Repr. 1A
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H361f
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H361f
H301
H373**
H410
607-509-00-2
2-phenoxyethyl 4-aminobenzoate
430-880-5
88938-23-2
Aquatic Chronic 2
H411
GHS09
H411
607-510-00-8
(2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
427-200-4
76646-91-8
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
607-511-00-3
reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;
4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid
423-750-4
— Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
607-514-00-X
potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate
427-240-2
134841-35-3
Skin Sens. 1
H317
GHS07
Wng
H317
607-518-00-1
3-oxoandrost-4-ene-17-β-carboxylic acid
414-990-0
302-97-6
Repr. 1A
Aquatic Chronic 4
H361f
H413
GHS08
Dgr
H361f
H413
607-519-00-7
poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-280-0
176429-27-9
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410
607-520-00-2
reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;
disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate
427-740-0
— Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-521-00-8
tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate
429-270-1
136210-30-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-522-00-3
sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate
429-720-7
184246-86-4
Aquatic Chronic 3
H412
— H412
607-523-00-9
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate
430-200-7
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-524-00-4
tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters
430-310-5
— Aquatic Chronic 4
H413
H413
607-525-00-X
(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid
431-520-1
64485-90-1
Flam. Sol. 1****
Carc. 2
Aquatic Chronic 3
H228
H351
H412
GHS02
GHS08
Dgr
H228
H351
H412
607-528-00-6
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid
430-900-2
192725-50-1
Eye Dam. 1
H318
GHS05
Dgr
H318
607-529-00-1
benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate
426-070-6
67299-45-0
Aquatic Chronic 3
H412
— H412
607-530-00-7
reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate
406-040-9
125643-61-0
Aquatic Chronic 4
H413
— H413
607-531-00-2
methyl 3-amino-4,6-dibromo-2-methyl-benzoate
425-190-6
119916-05-1
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411
607-532-00-8
(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt
425-510-4
167944-94-7
Aquatic Chronic 3
H412
— H412
607-533-00-3
pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
414-910-4
— Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-534-00-9
ethyl 2-(3-benzoylphenyl)propanoate
414-920-9
60658-04-0
Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Chronic 2
H301
H372**
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H372**
H317
H411
607-535-00-4
potassium 4-iodo-2-sulfonato-benzoic acid
426-620-5
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-536-00-X
(2,6-xylyloxy) acetic acid
430-910-7
13335-71-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
607-537-00-5
isopropylammonium 2-(3-benzoylphenyl)propionate
417-970-1
— Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H372**
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H312
H372**
H318
H410
607-539-00-6
propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate
431-000-2
198705-81-6
Aquatic Chronic 4
H413
— H413
607-540-00-1
1-(mercaptomethyl)cyclopropylacetic acid
420-240-3
162515-68-6
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H312
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H317
H411
607-541-00-7
[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)
421-940-1
28698-31-9
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
607-542-00-2
methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate
422-110-1
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-543-00-8
poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-480-8
176429-22-4
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410
607-544-00-3
ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate
427-490-2
158585-86-5
Aquatic Chronic 3
H412
— H412
607-545-00-9
1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate
424-070-0
94346-09-5
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-546-00-4
reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate;
methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate
424-290-7
188070-47-5
Skin Sens. 1
H317
GHS07
Wng
H317
607-547-00-X
18-methylnonadecyl 2,2 -dimethylpropanoate
424-370-1
125496-22-2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic
H315
H317
H413
GHS07
Wng
H315
H317
H413
607-548-00-5
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate
431-010-7
154486-26-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
607-549-00-0
methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate
424-430-7
125778-19-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-550-00-6
2-amino-4-bromo-5-chlorobenzoic acid
424-700-4
— Eye Dam. 1
Aquatic Chronic 3
H318
H410
GHS05
Dgr
H318
H410
607-551-00-1
tetrabutylammonium 2-amino-6-iodopurinate
424-710-9
156126-48-6
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H373**
H315
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373**
H315
H318
H317
H411
607-552-00-7
hexadecyl 3-amino-4-isopropoxybenzoate
424-830-1
— Aquatic Chronic 4
H413
— H413
607-553-00-2
7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt
424-850-0
— Eye Dam. 1
H318
GHS05
Dgr
H318
607-554-00-8
2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid
424-870-1
27624-67-5
Expl. 1.1
Eye Dam. 1
Aquatic Chronic 3
H201
H318
H412
GHS01
GHS05
Dgr
H201
H318
H412
607-555-00-3
1,1,3,3-tetramethylbutylperoxypivalate
424-980-8
22288-41-1
Flam. Liq. 2
Org. Perox. D
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H242
H315
H317
H411
GHS02
GHS07
GHS09
Dgr
H225
H242
H315
H317
H411
607-556-00-9
2-acetoxymethylene-4-acetylphenylacetate
425-160-2
24085-06-1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H318
H317
H400
H410
GHS05 GHS08 GHS07 GHS09 Dgr
H302
H373**
H318
H317
H410
607-557-00-4
salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid
425-210-3
169939-84-8
Skin Sens. 1
H317
GHS07
Wng
H317
607-558-00-X
2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]-oxathiolane-2-carboxylate
425-250-1
147027-10-9
Aquatic Chronic 2
H411
GHS09
H411
607-559-00-5
coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid
425-400-6
179986-09-5
Aquatic Chronic 4
H413
— H413
607-560-00-0
(R,S)-2-butyloctanedioic acid
431-210-4
50905-10-7
Eye Dam. 1
H318
GHS05
Dgr
H318
607-561-00-6
sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate
425-460-3
— Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-562-00-1
reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;
(2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate
425-530-3
98769-75-6
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
607-563-00-7
5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid
431-250-2
171850-30-9
Aquatic Chronic 2
H411
GHS09
H411
607-564-00-2
1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate
425-730-0
51178-75-7
Skin Sens. 1
H317
GHS07
Wng
H317
607-565-00-8
3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
425-820-1
88150-42-9
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373**
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H373**
H318
H410
607-566-00-3
reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;
bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate
426-140-6
— Aquatic Chronic 4
H413
— H413
607-567-00-9
potassium 3-iodo-6-methylbenzenesulfonate
426-300-5
— Eye Dam. 1
H318
GHS05
Dgr
H318
607-568-00-4
potassium 2-chloro-3-(benzyloxy)propionate
426-350-8
138666-92-9
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
607-569-00-X
reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;
sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate
426-470-0
— Skin Sens. 1
H317
GHS07
Wng
H317
607-570-00-5
sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate
426-520-1
71420-85-4
Skin Sens. 1
H317
GHS07
Wng
H317
607-571-00-0
2-cyclopentene-1-acetic acid,3-hydroxy-2-pentyl-, methyl ester acetate
431-400-7
57374-49-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-572-00-6
diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate
426-790-0
162208-27-7
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373**
H317
H410
607-573-00-1
reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;
disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate
426-840-1
— Eye Dam. 1
H318
GHS05
Dgr
H318
607-574-00-7
[1R-(1-α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate
426-890-4
77341-67-4
Eye Dam. 1
H318
GHS05
Dgr
H318
607-575-00-2
4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt
426-900-7
— STOT SE 3
Aquatic Chronic 3
H335
H412
GHS07
Wng
H335
H412
607-576-00-8
branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate
427-030-0
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-577-00-3
(2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate
427-100-0
— Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
607-578-00-9
ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate
427-110-5
— Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 4
H302
H373**
H413
GHS08
GHS07
Wng
H302
H373**
H413
607-579-00-4
diethyl[(p-ethoxyanilino)methylene]malonate
431-430-0
103976-28-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-580-00-X
ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate
422-360-1
100491-29-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-581-00-5
ethyl 2-ethoxy-4-carboxymethylbenzoate
427-630-2
99469-99-5
Eye Dam. 1
H318
GHS05
Dgr
H318
607-582-00-0
reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
427-650-1
— Aquatic Chronic 3
H412
— H412
607-583-00-6
4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid
427-680-5
188907-52-0
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-584-00-1
trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate
427-710-7
215612-56-9
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-585-00-7
strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate
427-930-3
— Skin Sens. 1
H317
GHS07
Wng
H317
607-586-00-2
dodecyl 3-amino-4-chlorobenzoate
428-020-9
6195-20-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-587-00-8
ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate
428-030-3
67914-69-6
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410
607-588-00-3
reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;
bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate
428-050-2
— Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-589-00-9
tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate
428-070-1
91788-83-9
STOT RE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H372**
H302
H410
607-590-00-4
hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate
428-140-1
210706-50-6
Aquatic Chronic 4
H413
— H413
607-591-00-X
reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;
disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate
428-400-4
— Eye Dam.
H318
GHS05
Dgr
H318
607-592-00-5
di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate
428-870-0
— Aquatic Chronic 4
H413
— H413
607-593-00-0
4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate
429-000-2
159235-16-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-594-00-6
ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
429-020-1
204254-96-6
STOT RE 2 *
Skin Sens. 1
H373**
H317
GHS08
GHS07
Wng
H373**
H317
607-595-00-1
N-amidino-N-methylglycine-2-oxopropionate
429-120-5
208535-04-0
Eye Dam. 1
H318
GHS05
Dgr
H318
607-596-00-7
ethyl 2-(4-phenoxyphenyl)lactate
429-220-9
132584-17-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-597-00-2
tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate
429-230-3
— Eye Dam. 1
H318
GHS05
Dgr
H318
607-598-00-8
trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate
429-240-8
212652-59-0
Eye Dam. 1
H318
GHS05
Dgr
H318
607-599-00-3
1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate
431-610-9
68860-54-8
Org. Perox. D
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H317
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H317
H410
607-600-00-7
(1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate
431-700-8
— Aquatic Chronic 2
H411
GHS09
H411
607-601-00-2
1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate
429-370-5
220410-74-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-602-00-8
ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate
429-680-0
122665-86-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-603-00-3
lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate
429-730-1
193562-37-7
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-604-00-9
guanidinium benzoate
429-820-0
26739-54-8
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-605-00-4
methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate
429-890-2
144550-06-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-606-00-X
(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid
430-100-3
86978-24-7
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-607-00-5
reaction mass of: calcium bis(C10-14 branched alkyl salicylate);
calcium bis(C18-30-alkyl salicylate);
calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;
calcium bis (C10-14 branched alkyl phenolate);
calcium bis (C18-30-alkyl phenolate);
calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;
C10-14 branched alkyl phenol;
C18-30-alkyl phenol
430-180-1
— Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-608-00-0
pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate
430-210-1
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-609-00-6
ethyl (3R)-4-cyano-3-hydroxybutanoate
430-220-6
141942-85-0
Eye Irrit. 2
H319
GHS07
Wng
H319
607-610-00-1
trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate
430-280-3
— Skin Sens. 1
H317
GHS07
Wng
H317
607-611-00-7
methyl 3-amino-2,2,3-trimethylbutyrate
431-720-7
90886-53-6
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412
607-612-00-2
reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;
ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate
432-190-1
182176-52-9
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
H302
H373**
H318
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
607-613-00-8
reaction mass of: succinic acid;
monopersuccinic acid;
dipersuccinic acid;
monomethyl ester of succinic acid;
monomethyl ester of persuccinic acid;
dimethyl succinate;
glutaric acid;
monoperglutaric acid;
diperglutaric acid;
monomethyl ester of glutaric acid;
monomethyl ester of perglutaric acid;
dimethyl glutarate;
adipic acid;
monoperadipic acid;
diperadipic acid;
monomethyl ester of adipic acid;
monomethyl ester of peradipic acid;
dimethyl adipate;
hydrogen peroxide;
methanol;
water
432-790-1
— Muta. 2
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H341
H314
H332
H312
H302
GHS05
GHS08
GHS07
Dgr
H341
H314
H332
H312
H302
607-614-00-3
2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid
426-480-5
63562-33-4
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-615-00-9
reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance
431-120-5
— Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H331
H302
H319
H317
GHS06
Dgr
H331
H302
H319
H317
607-616-00-4
2,4-dichloro-5-fluorobenzoylchloride
428-390-1
86393-34-2
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H335
H315
H318
H317
H412
GHS05
GHS07
Dgr
H335
H315
H318
H317
H412
607-617-00-X
bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate
430-700-5
10138-36-0
Skin Sens. 1
H317
GHS07
Wng
H317
607-618-00-5
menadione sodium bisulfite;
2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt
204-987-0
130-37-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
607-619-00-0
menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)
277-543-7
73581-79-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
607-620-00-6
trisodium nitrilotriacetate
225-768-6
5064-31-3
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
H351
H302
H319
GHS08
GHS07
Wng
H351
H302
H319
Carc. 2; H351: C ≥ 5 %
607-621-00-1
milbemectin (ISO);
[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]
— —
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410
M=100
607-622-00-7
2-ethylhexyl-2-ethylhexanoate
231-057-1
7425-14-1
Repr. 2
H361d***
GHS08
Wng
H361d***
607-623-00-2
diisobutyl phthalate
201-553-2
84-69-5
Repr. 1B
H360Df
GHS08
Dgr
H360Df
Repr. 1B; H360Df: C ≥ 25 %
Repr. 2; H361f: 5 % ≤ C < 25 %
607-624-00-8
perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5]
217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]
1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]
Carc. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Lact.
Aquatic Chronic 2
H351
H360D***
H372**
H332
H302
H362
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D***
H372**
H332
H302
H362
H411
607-625-00-3
clodinafop-propargyl (ISO)
— 105512-06-9
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H410
Skin Sens. 1; H317: C ≥ 0,001 %
M=1
607-626-00-9
ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate
401-290-5
103112-35-2
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
607-627-00-4
[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate
416-360-0
162221-28-5
Skin Sens. 1
H317
GHS07
Wng
H317
607-628-00-X
4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine
419-240-6
171054-89-0
Eye Dam. 1
H318
GHS05
Dgr
H318
607-629-00-5
[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid
419-270-1
123599-82-6
Eye Irrit. 2
H319
GHS07
Wng
H319
607-630-00-0
acrylic acid,3-(trimethoxysilyl)propyl ester
419-560-6
4369-14-6
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H332
H314
H317
H412
GHS05
GHS07
Dgr
H332
H314
H317
H412
607-631-00-6
reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate
442-300-8
— Skin Sens. 1
H317
GHS07
Wng
H317
607-632-00-1
N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide
420-210-1
111244-14-5
Aquatic Chronic 4
H413
— H413
607-633-00-7
trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate
440-480-2
341026-59-3
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-634-00-2
(S)-(-)-2-acetoxypropionylchloride;
(1S)-2-chloro-1-methyl-2-oxoethyl acetate
420-610-4
36394-75-9
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
607-635-00-8
trisodium N-(3-propionato)-l-aspartate
422-090-4
172737-80-3
Eye Dam. 1
H318
GHS05
Dgr
H318
607-636-00-3
1-bromo-2-methylpropyl propionate
422-900-6
158894-67-8
Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Skin Sens. 1
H226
H351
H314
H317
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H351
H314
H317
607-637-00-9
disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate
423-730-5
250688-43-8
Eye Dam. 1
H318
GHS05
Dgr
H318
607-638-00-4
2-hydroxybenzoic acid 2-butyloctyl ester
431-090-3
190085-41-7
Aquatic Chronic 4
H413
— H413
607-639-00-X
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate
431-770-1
216698-07-6
Aquatic Chronic 4
H413
— H413
607-641-00-0
2-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid
431-930-9
43028-69-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
607-642-00-6
3,6,9-trithiaundecamethylene-1,11-dimethacrylate
432-210-7
141631-22-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-643-00-1
dimethyl (2S)-2-hydroxysuccinate
432-310-0
617-55-0
Flam. Liq. 3
Eye Dam. 1
Skin Sens. 1
H226
H318
H317
GHS02
GHS05
GHS07
Dgr
H226
H318
H317
607-644-00-7
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate
432-350-9
81752-87-6
Skin Irrit. 2
H315
GHS07
Wng
H315
607-645-00-2
tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate
432-550-6
243858-01-7
Eye Dam. 1
H318
GHS05
Dgr
H318
607-646-00-8
d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;
tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
432-960-5
124655-09-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-647-00-3
5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane
433-530-1
143446-73-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
H302
H317
H400
GHS07
GHS09
Wng
H302
H317
H400
607-649-00-4
[3-(chlorocarbonyl)-2-methylphenyl]acetate
433-690-0
167678-46-8
Skin Corr. 1A
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
607-650-00-X
2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate
433-910-5
145153-52-2
Skin Sens. 1
H317
GHS07
Wng
H317
607-651-00-5
sodium 2-(nonanoyloxy)benzenesulfonate
434-360-9
91125-43-8
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-652-00-0
ethyl N
2-dodecanoyl-l-argininate hydrochloride
434-630-6
60372-77-2
Eye Dam. 1
Aquatic Acute 1
H318
H400
GHS05
GHS09
Dgr
H318
H400
607-653-00-6
tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate
434-840-8
225786-91-4
Aquatic Chronic 2
H411
GHS09
H411
607-654-00-1
(S)-3-hydroxy-γ-butyrolactone
434-990-4
7331-52-4
Skin Sens. 1
H317
GHS07
Wng
H317
607-655-00-7
ethyl 6,8-dichlorooctanoate
435-080-1
1070-64-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-656-00-2
sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid
435-350-7
141250-43-3
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-657-00-8
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
436-920-8
172399-10-9
Eye Dam. 1
H318
GHS05
Dgr
H318
607-658-00-3
3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt
440-770-9
371921-63-0
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-659-00-9
pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid
442-030-0
321912-47-4
Eye Dam. 1
H318
GHS05
Dgr
H318
607-660-00-4
2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt
442-230-8
321679-52-1
Eye Dam. 1
H318
GHS05
Dgr
H318
607-661-00-X
1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate
442-850-9
114772-40-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-662-00-5
methyl 2-(acetylamino)-3-chloropropionate
442-860-3
87333-22-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-663-00-0
bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate
442-980-6
127474-91-3
Aquatic Chronic 4
H413
— H413
607-664-00-6
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate
443-120-2
393509-79-0
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
607-665-00-1
trans-methyl-2-ethyl-but-2-enoate
443-150-6
101226-85-1
Flam. Liq. 3
H226
GHS02
Wng
H226
607-666-00-7
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid
443-560-5
88784-33-2
Eye Irrit. 2
H319
GHS07
Wng
H319
607-667-00-2
chloro-1-ethylcyclohexyl carbonate
444-950-8
99464-83-2
Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Wng
H341
H317
607-668-00-8
trans-2-isopropyl-5-carboxy-1,3-dioxane
445-770-2
42031-28-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-669-00-3
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate
445-990-9
376588-17-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-670-00-9
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate
448-700-9
500791-70-8
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373**
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H373**
H318
H317
H410
M=10
607-671-00-4
diethyl 1,4-cyclohexanedicarboxylate
417-310-0
72903-27-6
Aquatic Chronic 2
H411
GHS09
H411
607-672-00-X
reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate
419-000-0
— Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-673-00-5
1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate
419-570-0
— Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
607-675-00-6
reaction mass of: cis-9-octadecenedioic acid;
cis-9-cis-12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid
422-260-8
— Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
607-676-00-1
reaction mass of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid
423-670-1
— Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-677-00-7
2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-l-valinate
424-660-8
— STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H373**
H318
H317
607-678-00-2
reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate
427-090-8
— Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-679-00-8
reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);
3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);
3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)
431-440-5
— Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
607-680-00-3
tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
432-810-9
— Aquatic Chronic 4
H413
— H413
607-681-00-9
reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate
432-910-2
— Aquatic Chronic 4
H413
— H413
607-682-00-4
complex reaction mass of Chinese gum rosin post reacted with acrylic acid
434-230-1
144413-22-9
Aquatic Chronic 4
H413
— H413
607-683-00-X
reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)
435-450-0
— Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-684-00-5
alkenes,C12-14, hydroformylation products, distn. residues,C-(hydrogen sulfobutanedioates), disodium salts
435-660-2
243662-67-1
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
607-685-00-0
ammonium 2-cocoyloxyethanesulfonate
441-050-7
— Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318
607-686-00-6
6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)
441-550-5
— Self-react. C ****
Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351
607-687-00-1
reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)
442-800-6
— Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-688-00-7
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride
444-320-2
— Acute Tox. 4 *
H302
GHS07
Wng
H302
607-689-00-2
reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate („para-isomer” including cis- and trans- isomers);
methyl 1,3-dimethylcyclohexanecarboxylate („meta-isomer” including cis- and trans-isomers)
444-920-4
— Aquatic Chronic 3
H412
— H412
607-690-00-8
dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate
432-860-1
255387-46-3
Skin Sens. 1
H317
GHS07
Wng
H317
607-691-00-3
magnesium salts, fatty acids,C16-18 and C18 unsaturated, branched and linear
448-690-6
— Aquatic Chronic 4
H413
— H413
607-692-00-9
zinc salts, fatty acids,C16-18 and C18 unsaturated, branched and linear
446-470-4
— Aquatic Chronic 4
H413
— H413
607-693-00-4
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate
443-860-6
302776-68-7
Aquatic Chronic 4
H413
— H413
607-694-00-X
ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate
443-870-0
163520-33-0
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
608-020-00-7
diphenoxymethylenecyanamide
427-300-8
79463-77-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
608-032-00-2
acetamiprid (ISO);
(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
— 135410-20-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
608-042-00-7
(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide
421-810-4
194602-27-2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
608-044-00-8
2-cyclohexylidene-2-phenylacetonitrile
423-740-1
10461-98-0
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
608-046-00-9
5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile
425-310-7
77889-90-8
Aquatic Chronic 4
H413
— H413
608-047-00-4
2-piperidin-1-yl-benzonitrile
427-330-1
72752-52-4
Aquatic Chronic 2
H411
GHS09
H411
608-048-00-X
1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile
427-450-4
152630-47-2
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H302
H373**
H317
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H411
608-049-00-5
2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile
429-180-2
157362-53-3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
608-050-00-0
reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;
5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile
429-760-5
— Aquatic Chronic 4
H413
— H413
608-051-00-6
(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-760-2
219861-18-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
608-052-00-1
(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-770-7
128173-52-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
608-053-00-7
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-780-1
103146-25-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
608-054-00-2
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate
430-790-6
— Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
608-055-00-8
fipronil (ISO);
5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile
— 120068-37-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H372**
H410
M=10
608-056-00-3
N-methyl-N-cyanomethylmorpholiniummethylsulfate
429-340-1
— Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
608-057-00-9
4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate
431-200-1
208538-34-5
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
608-059-00-X
5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile
421-240-6
120068-79-3
Aquatic Chronic 2
H411
GHS09
H411
608-060-00-5
5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile
421-300-1
138564-59-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
608-062-00-6
2-fluoro-4-hydroxybenzonitrile
422-810-7
82380-18-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
608-063-00-1
(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile
441-070-6
61826-76-4
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410
608-064-00-7
cyanomethyltrimethylammoniummethylsulfate
433-720-2
— Aquatic Chronic 3
H412
— H412
609-069-00-7
musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone
201-328-9
81-14-1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
609-072-00-3
4-mesyl-2-nitrotoluene
430-550-0
1671-49-4
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H361f***
H302
H317
H412
GHS08
GHS07
Dgr
H361f***
H302
H317
H412
609-073-00-9
lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato]}-N'-(2-aminoethyl)piperazine
427-850-9
— Skin Sens. 1
H317
GHS07
Wng
H317
611-050-00-3
reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate
415-350-3
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-102-00-5
reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid;
disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid
424-500-7
— Aquatic Chronic 3
H412
— H412
611-139-00-7
reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride
424-510-1
— Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
611-141-00-8
5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt
414-410-6
— Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-142-00-3
product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;
sodium chloride
425-740-5
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-143-00-9
reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);
trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)
428-260-4
— Eye Dam. 1
H318
GHS05
Dgr
H318
611-144-00-4
reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
429-070-4
214362-06-8
Eye Dam. 1
H318
GHS05
Dgr
H318
611-145-00-X
reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate;
3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt
429-440-5
— Eye Dam. 1
H318
GHS05
Dgr
H318
611-146-00-5
reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate
430-070-1
— Aquatic Chronic 2
H411
GHS09
H411
611-147-00-0
sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate
430-090-0
205764-96-1
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-148-00-6
reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;
2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;
3-(2,6-dichloro-4-nitrophenylazo)carbazol
429-590-1
— Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
611-149-00-1
2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate
427-570-7
193486-83-8
Aquatic Chronic 2
H411
GHS09
H411
611-150-00-7
tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate
440-460-3
— Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
611-151-00-2
chrysoidine;
4-(phenylazo)benzene-1,3-diamine
207-803-7
495-54-5
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H315
H410
611-152-00-8
chrysoidine monohydrochloride;
4-phenylazophenylene-1,3-diamine monohydrochloride; [1]
chrysoidine monoacetate;
4-(phenylazo)benzene-1,3-diamine monoacetate; [2]
chrysoidine acetate;
4-(phenylazo)benzene-1,3-diamine acetate; [3]
chrysoidine-p-dodecylbenzenesulfonate;
dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]
chrysoidine dihydrochloride;
4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]
chrysoidine sulfate;
bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]
208-545-8 [1]
278-290-5 [2]
279-116-0 [3]
264-409-8 [4]
281-549-5 [5]
282-432-1 [6]
532-82-1 [1]
75660-25-2 [2]
79234-33-6 [3]
63681-54-9 [4]
83968-67-6 [5]
84196-22-5 [6]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H341
H302
H315
H318
H410
611-153-00-3
chrysoidine C10-14-alkyl derivatives;
benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]
chrysoidine compound with dibutylnaphthalene sulfonic acid;
dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]
286-946-7 [1]
304-236-8 [2]
85407-90-5 [1]
94247-67-3 [2]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H341
H302
H315
H318
GHS05
GHS08
GHS07
Dgr
H341
H302
H315
H318
611-154-00-9
trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate
403-670-6
92408-46-3
Aquatic Chronic 3
H412
— H412
611-155-00-4
4,4'-oxybis(benzenesulfonylazide)
431-850-4
7456-68-0
Expl. 1.1****
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H373**
H400
H410
GHS01
GHS08
GHS09
Dgr
H201
H373**
H410
611-156-00-X
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate
432-270-4
221354-37-6
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H361f***
H373**
H411
GHS08
GHS09
Wng
H361f***
H373**
H411
611-157-00-5
benzenesulfonic acid,3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate
432-590-4
243869-48-9
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
611-158-00-0
reaction product of: 2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride
421-520-8
— ****
Aquatic Chronic 4
****
H413
****
****
H413
611-159-00-6
disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate
421-880-6
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-160-00-1
reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;
1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)
422-760-6
— ****
Aquatic Chronic 4
****
H413
****
****
H413
611-161-00-7
trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)
423-100-1
— Eye Dam. 1
H318
GHS05
Dgr
H318
611-162-00-2
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)
429-600-4
— Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
611-163-00-8
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate
429-610-9
— Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
611-164-00-3
reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;
2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2,2'-dimethyl-2,2'-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)
429-710-2
— Self React D
Acute Tox. 4 *
Aquatic Chronic 2
H242
H302
H411
GHS02
GHS07
GHS09
Dgr
H242
H302
H411
611-165-00-9
reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
431-830-5
— Aquatic Chronic 3
H412
— H412
611-166-00-4
reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
432-100-9
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-167-00-X
sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)
435-240-9
— Aquatic Chronic 3
H412
— H412
611-168-00-5
reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid
435-440-6
— Eye Dam. 1
H318
GHS05
Dgr
H318
611-169-00-0
sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate
435-800-2
— Aquatic Chronic 3
H412
— H412
611-170-00-6
reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2
)-1-phenylmethyl)azo-κ-N1
)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2
)-1-phenylmethyl)azo-κ-N1
)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)
435-880-9
— Aquatic Chronic 3
H412
— H412
611-171-00-1
reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate
436-890-6
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-172-00-7
reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate
438-310-7
— Self-react. C****
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H242
H361f***
H302
H373**
H412
GHS02
GHS08
GHS07
Dgr
H242
H361f***
H302
H373**
H412
611-173-00-2
reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt
440-510-4
— Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-174-00-8
reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt
442-290-5
457624-86-1
Eye Dam. 1
H318
GHS05
Dgr
H318
611-175-00-3
reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate
444-050-5
— Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-176-00-9
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate
444-250-2
— Self-react. C****
Aquatic Chronic 2
H242
H411
GHS02
GHS09
Dgr
H242
H411
611-177-00-4
reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)
444-290-0
508202-43-5
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
611-178-00-X
reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
445-280-9
— Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
611-179-00-5
reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate
450-010-8
— Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-180-00-0
iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts
417-850-7
— Aquatic Chronic 2
H411
GHS09
H411
612-057-01-1
piperazine;
[liquid]
203-808-3
110-85-0
Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H361fd
H314
H334
H317
GHS05
GHS08
Dgr
H361fd
H314
H334
H317
612-122-01-4
hydroxylamine … % [≤ 55 % in aqueous solution]
232-259-2
7803-49-8
Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
B
612-169-00-3
bis(N-methyl-N-phenylhydrazine)sulfate
423-170-1
618-26-8
Flam. Liq. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H225
H372**
H302
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H225
H372**
H302
H318
H317
H410
612-203-00-7
C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %-85 %, chain > C10: <3 %)
417-360-3
— Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
H312
H302
H315
GHS07
Wng
H312
H302
H315
612-208-00-4
N-methylbenzene-1,2-diammonium hydrogen phosphate
424-460-0
— Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
612-216-00-8
1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt
425-870-2
19450-38-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
612-219-00-4
(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride
402-200-7
— Aquatic Chronic 3
H412
— H412
612-220-00-X
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine
431-060-1
153719-38-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
612-221-00-5
2-amino-4-(trifluoromethyl)benzenethiol hydrochloride
429-560-8
4274-38-8
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H314
H332
H312
H302
H373**
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H312
H302
H373**
H317
H400
612-222-00-0
cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine
425-080-8
104860-26-6
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373**
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373**
H318
H410
612-223-00-6
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine
425-300-2
186450-73-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
612-224-00-1
N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine
426-150-0
121246-28-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
612-225-00-7
1,4,7,10-tetraazacyclododecane
425-450-9
294-90-6
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H312
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H410
612-226-00-2
3-(2'-phenoxyethoxy)propylamine
427-870-8
6903-18-0
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H315
H318
H412
GHS05
GHS07
Dgr
H302
H315
H318
H412
612-227-00-8
benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride
428-290-8
120606-08-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
612-228-00-3
reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine
414-340-6
— Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H226
H332
H312
H302
H371
H318
H317
H412
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H332
H312
H302
H371
H318
H317
H412
612-229-00-9
mepanipyrim;
4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine
— 110235-47-7
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
612-230-00-4
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide
431-530-4
— Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
612-231-00-X
3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride
427-370-1
164288-56-6
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
612-232-00-5
reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;
triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid
430-410-9
186148-38-9
Aquatic Chronic 3
H412
— H412
612-237-00-2
hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]
233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]
10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]
Expl. 1.1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H312
H302
H373**
H319
H315
H317
H400
HS01
GHS08
GHS07
GHS09
Dgr
H201
H351
H312
H302
H373**
H319
H315
H317
H400
T
612-238-00-8
(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %
222-048-3
3327-22-8
Carc. 2
Aquatic Chronic 3
H351
H412
GHS08
Wng
H351
H412
B
612-239-00-3
biphenyl-3,3',4,4'-tetrayltetraamine;
diaminobenzidine
202-110-6
91-95-2
Carc. 1B
Muta. 2
H350
H341
GHS08
Dgr
H350
H341
612-240-00-9
pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl)aniline
— 53112-28-0
Aquatic Chronic 2
H411
GHS09
H411
612-241-00-4
piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]
228-042-7 [1]
205-551-2 [2]
217-775-8 [3]
6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]
Repr. 2
Eye Irrit. 2
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H361fd
H319
H315
H334
H317
H412
GHS08
Dgr
H361fd
H319
H315
H334
H317
H412
612-242-00-X
cyprodinil (ISO);
4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine
— 121552-61-2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10
612-243-00-5
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate
420-560-3
79617-97-3
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
M=10
612-244-00-0
3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride
421-310-6
87691-88-1
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H302
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f***
H302
H319
H317
H410
612-245-00-6
2-ethylphenylhydrazine hydrochloride
421-460-2
19398-06-2
Carc. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H372**
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H372**
H302
H318
H317
H410
M=10
612-246-00-1
(2-chloroethyl)(3-hydroxypropyl)ammonium chloride
429-740-6
40722-80-3
Carc. 1B
Muta. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H350
H340
H373**
H317
H412
GHS08
GHS07
Dgr
H350
H340
H373**
H317
H412
612-247-00-7
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide
423-530-8
152828-23-4
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 3
H372**
H302
H412
GHS08
GHS07
Dgr
H372**
H302
H412
612-248-00-2
reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10,C9-rich)
439-540-0
— Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
612-249-00-8
4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride
425-030-5
159939-85-2
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H361f***
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H361f***
H302
H314
H317
H411
612-250-00-3
chloro-N,N-dimethylformiminium chloride
425-970-6
3724-43-4
Repr. 1B
Acute Tox. 4 *
Skin Corr. 1A
H360D***
H302
H314
GHS05
GHS08
GHS07
Dgr
H360D***
H302
H314
EUH014
612-251-00-9
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
426-020-3
51229-78-8
Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H228
H361d***
H302
H315
H317
H411
GHS02
GHS08
GHS07
GHS09
Wng
H228
H361d***
H302
H315
H317
H411
612-252-00-4
imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine
428-040-8
138261-41-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
612-253-00-X
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Aquatic Chronic 3
H412
— H412
612-253-01-7
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing ≥ 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Repr. 1B
Aquatic Chronic 3
H360D***
H412
GHS08
Dgr
H360D***
H412
612-254-00-5
reaction products of diisopropanolamine with formaldehyde (1:4)
432-440-8
220444-73-5
Carc. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H351
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H302
H314
H317
H411
612-255-00-0
1-(3-methoxypropyl)-4-piperidinamine
431-950-8
179474-79-4
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H312
H302
H314
H412
GHS05
GHS07
Dgr
H312
H302
H314
H412
612-256-00-6
benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate
427-470-3
137864-22-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
612-257-00-1
tripropylammonium dihydrogenphosphate
433-700-3
35687-90-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
612-259-00-2
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine
437-720-3
227085-51-0
Eye Dam. 1
H318
GHS05
Dgr
H318
612-261-00-3
3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline
441-190-9
121451-05-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=10
612-265-00-5
bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate
444-360-0
191617-13-7
Aquatic Chronic 3
H412
— H412
612-266-00-0
3-chloro-4-(3-fluorobenzyloxy)aniline
445-590-4
202197-26-0
Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H373**
H410
612-267-00-6
bis(hydrogenated tallow C16-18-alkyl)hydroxylamine
418-370-0
— Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
612-269-00-7
reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline
420-720-2
— Aquatic Chronic 4
H413
— H413
612-270-00-2
(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride
433-010-2
— Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
612-271-00-8
reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate
434-970-5
160987-57-5
Aquatic Chronic 4
H413
— H413
612-272-00-3
ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate
435-210-5
— Aquatic Chronic 2
H411
GHS09
H411
612-273-00-9
alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride
435-650-8
— Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
612-274-00-4
(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate
445-750-3
— Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
612-275-00-X
fatty acids,C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil
447-880-6
206565-89-1
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
M=10
612-276-00-5
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts
451-430-4
500717-36-2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
612-277-00-0
reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium
451-440-9
586372-44-3
Eye Dam. 1
H318
GHS05
Dgr
H318
612-278-00-6
ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide
214-984-6
1239-45-8
Muta. 2
Acute Tox. 2 *
Acute Tox. 4 *
H341
H330
H302
GHS06
GHS08
Dgr
H341
H330
H302
612-279-00-1
(R,S)-2-amino-3,3-dimethylbutane amide
447-860-7
144177-62-8
Repr. 2
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H361f***
H373**
H319
H315
H317
GHS08
GHS07
Wng
H361f***
H373**
H319
H315
H317
612-280-00-7
3-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine
205-057-7
132-32-1
Carc. 1B
H350
GHS08
Dgr
H350
H
613-116-01-4
tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H319
H335
H315
H317
H400
GHS07
GHS09
Wng
H319
H335
H315
H317
H400
M=10
613-161-00-2
2,4-diamino-6-hydroxymethylpteridinehydrobromide
430-620-0
76145-91-0
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373**
H317
H412
GHS08
GHS07
Wng
H373**
H317
H412
613-162-00-8
(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide
423-260-0
100988-63-4
Muta. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H317
H411
613-187-00-4
5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene
410-530-8
— Skin Sens. 1
H317
GHS07
Wng
H317
613-192-00-1
3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane
426-750-2
151860-15-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-198-00-4
2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine
415-500-8
145963-84-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
613-229-00-1
1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine
411-930-5
106917-31-1
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
613-231-00-2
2,6-diamino-3-((pyridine-3-yl)azo)pyridine
421-430-9
28365-08-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373**
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H411
613-232-00-8
3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide
431-030-6
163269-30-5
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H373**
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H331
H373**
H318
H410
613-234-00-9
imidazo[1,2-b]pyridazin hydrochloride
431-510-5
18087-70-2
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
613-235-00-4
2,3-dihydro-2,2-dimethyl-1H-perimidine
424-060-6
6364-17-6
Acute Tox. 4*
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H410
613-236-00-X
2-chloro-3-trifluoromethylpyridine
424-520-6
65753-47-1
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Chronic 3
H311
H301
H372**
H314
H412
GHS06
GHS05
GHS08
Dgr
H311
H301
H372**
H314
H412
613-237-00-5
6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine
424-950-4
133949-92-5
Aquatic Chronic 4
H413
— H413
613-238-00-0
sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate
430-890-1
81992-66-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
613-239-00-6
2-[3-(methylamino)propyl]-1H-benzimidazole
425-760-4
64137-52-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
613-241-00-7
3-(2H-tetrazol-5-yl)pyridine
426-810-8
3250-74-6
Eye Dam. 1
H318
GHS05
Dgr
H318
613-242-00-2
reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid,2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts
426-860-0
191877-09-5
Eye Dam. 1
H318
GHS05
Dgr
H318
613-243-00-8
4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)
427-350-0
182235-14-9
Aquatic Chronic 2
H411
GHS09
H411
613-244-00-3
5,7-dichloro-4-hydroxyquinoline
427-420-0
21873-52-9
Aquatic Chronic 2
H411
GHS09
H411
613-245-00-9
2-fluoro-6-trifluoromethylpyridine
428-100-3
94239-04-0
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H226
H332
H302
H412
GHS02
GHS07
Wng
H226
H332
H302
H412
613-246-00-4
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
428-200-7
103577-66-8
Aquatic Chronic 3
H412
— H412
613-247-00-X
3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole
428-910-7
107786-36-7
Aquatic Chronic 4
H413
— H413
613-248-00-5
3,4-dimethyl-1H-pyrazole
429-130-1
2820-37-3
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
613-249-00-0
1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate
429-300-3
155601-30-2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
613-250-00-6
reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;
methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;
2-isopropyl-N-hydroxyethyl 1,3-oxazolidine
429-990-6
— Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
613-251-00-1
(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole
430-560-5
180637-89-2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
613-253-00-2
2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;
reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3.5)
430-580-4
— Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
EUH019
613-254-00-8
forchlorfenuron (ISO);
1-(2-chloro-4-pyridyl)-3-phenylurea
— 68157-60-8
Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411
613-255-00-3
reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfonatophthalocyaninato)]copper(II)
424-270-8
— Eye Dam. 1
H318
GHS05
Dgr
H318
613-256-00-9
3'5'-anhydro thymidine
425-810-5
38313-48-3
Aquatic Chronic 3
H412
— H412
613-257-00-4
2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate
426-400-9
170222-39-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
613-258-00-X
reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;
4-chloro-5-methylbenzotriazole sodium salt;
5-chloro-4-methylbenzotriazole sodium salt
427-730-6
202420-04-0
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
613-259-00-5
reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;
[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate
428-790-6
72963-72-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-260-00-0
(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin
430-730-9
— Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
613-261-00-6
pyrazole-1-carboxamidine monohydrochloride
429-520-1
4023-02-3
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373**
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
H412
613-262-00-1
disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene
427-310-2
180850-95-7
Eye Dam. 1
H318
GHS05
Dgr
H318
613-263-00-7
monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate
429-570-2
— Skin Sens. 1
H317
GHS07
Wng
H317
613-266-00-3
2-chloro-5-chloromethylthiazole
429-830-5
105827-91-6
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H311
H314
H302
H317
H411
GHS06
GHS05
GHS09
Dgr
H311
H314
H302
H317
H411
613-267-00-9
thiamethoxam (ISO);
3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine
428-650-4
153719-23-4
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=10
613-268-00-4
(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine
425-930-8
151213-39-7
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H314
H332
H302
H373**
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H302
H373**
H411
613-269-00-X
2-thiazolidinylidenecyanamide
427-720-1
26364-65-8
Acute Tox. 4*
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
613-270-00-5
5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide
428-150-6
113171-13-4
Aquatic Chronic 3
H412
— H412
613-271-00-0
tritosulfuron (ISO) (containing ≤ 0,02 % AMTT);
1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)
— 142469-14-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10
613-272-00-6
pyraclostrobin (ISO);
methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate
— —
Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H315
H400
H410
GHS06
GHS09
Dgr
H331
H315
H410
M=100
613-273-00-1
tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine
427-600-9
192439-46-6
Aquatic Chronic 2
H411
GHS09
H411
613-274-00-7
2,6-dichloro-1-fluoropyridiniumtetrafluoroborate
427-400-1
140623-89-8
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H410
613-275-00-2
3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride
424-530-0
93076-03-0
Acute Tox. 3 *
STOT SE 2
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H301
H371**
H373**
H318
H317
H411
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H371
H373**
H318
H317
H411
613-276-00-8
1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one
426-110-2
98377-35-6
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-277-00-3
(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one
427-070-9
— Aquatic Chronic 4
H413
— H413
613-278-00-9
(3-aminophenyl)pyridin-3-ylmethanone
428-230-0
79568-06-2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
613-279-00-4
2-ethyl-2,3-dihydro-2-methyl-1H-perimidine
424-380-6
43057-68-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410
613-280-00-X
tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
dimethyl propyleneurea
230-625-6
7226-23-5
Repr. 2
Acute Tox. 4 *
Eye Dam. 1
H361f***
H302
H318
GHS05
GHS08
GHS07
Dgr
H361f***
H302
H318
613-281-00-5
quinoline
202-051-6
91-22-5
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H350
H341
H312
H302
H319
H315
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H312
H302
H319
H315
H411
613-282-00-0
triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol
— 131983-72-7
Aquatic Chronic 2
H411
GHS09
H411
613-283-00-6
ketoconazole;
1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
265-667-4
65277-42-1
Repr. 1B
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360F***
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H360F***
H301
H373**
H410
613-284-00-1
metconazole (ISO);
(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
— 125116-23-6
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H361d***
H302
H411
GHS08
GHS07
GHS09
Wng
H361d***
H302
H411
613-285-00-7
1-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]
219-989-7 [1]
219-989-7 [2]
2592-95-2 [1]
123333-53-9 [2]
Expl. 1.3
H203
GHS01
Dgr
H203
613-286-00-2
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]
418-260-2
183196-57-8
Skin Sens. 1
H317
GHS07
Wng
H317
613-286-01-X
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]
418-260-2
183196-57-8
Repr. 1B
Skin Sens. 1
H360D***
H317
GHS08
GHS07
Dgr
H360D***
H317
613-287-00-8
1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole
419-540-7
160194-26-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
613-288-00-3
1,3-bis(dimethylcarbamoyl)-imidazolium chloride
420-930-4
135756-61-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
613-289-00-9
3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole
432-020-4
142623-48-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-290-00-4
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride
432-470-1
189012-93-9
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
613-291-00-X
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
434-820-9
106461-41-0
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
613-292-00-5
N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine
435-010-8
26157-73-3
Muta. 2
Aquatic Chronic 3
H341
H412
GHS08
Wng
H341
H412
613-293-00-0
2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester
448-050-6
444065-11-6
Aquatic Chronic 4
H413
— H413
613-294-00-6
2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester
448-260-8
379268-96-9
Aquatic Chronic 4
H413
— H413
613-295-00-1
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride
448-720-8
363138-44-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
613-296-00-7
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate
418-270-7
— Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-297-00-2
5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole
420-820-6
— Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2
H226
H302
H411
GHS02
GHS07
GHS09
Wng
H226
H302
H411
613-298-00-8
bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate
421-560-6
— STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H373**
H318
H411
GHS05
GHS08
GHS09
Dgr
H373**
H318
H411
613-299-00-3
main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt
422-610-1
— Eye Dam. 1
H318
GHS05
Dgr
H318
613-300-00-7
1-imidazol-1-yl-octadecan-2-ol
434-120-3
— Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
613-301-00-2
dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate
443-910-7
— Aquatic Chronic 4
H413
— H413
613-302-00-8
disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate
432-980-4
243858-60-8
Eye Dam. 1
H318
GHS05
Dgr
H318
613-303-00-3
2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine
429-800-1
95737-68-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-304-00-9
5,6-dihydroxy-2,3-dihydro-1H-indolium bromide
421-170-6
138937-28-7
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
613-305-00-4
2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole
448-630-9
3147-77-1
Aquatic Chronic 4
H413
— H413
613-306-00-X
(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate
433-520-5
82911-69-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
613-307-00-5
clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine
— 210880-92-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=10
613-308-00-0
2-amino-5-methylthiazole
423-800-5
7305-71-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410
613-309-00-6
1-methyl-3-phenyl-1-piperazine
431-180-2
5271-27-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H312
H302
H315
H318
H412
GHS05
GHS07
Dgr
H312
H302
H315
H318
H412
613-310-00-1
(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride
432-360-3
105813-13-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
613-311-00-7
methyl-5-nitrophenyl-guanidine
435-500-1
152460-07-6
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H302
H319
H317
H412
GHS07
Wng
H302
H319
H317
H412
613-312-00-2
2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride
420-200-5
— Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
613-313-00-8
2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione
442-780-9
173838-67-0
Aquatic Chronic 3
H412
— H412
613-314-00-3
4-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one
443-770-7
7693-82-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-315-00-9
tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate
430-390-1
— Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412
613-316-00-4
trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)
257-765-0
52234-82-9
Muta. 2
Eye Dam. 1
Skin Sens. 1
H341
H318
H317
GHS05
GHS08
GHS07
Dgr
H341
H318
H317
H
615-033-00-1
reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0.097)
430-980-9
— Aquatic Chronic 4
H413
— H413
615-034-00-7
reaction product of diphenylmethanediisocyanate, octylamine,4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)
430-750-8
— Aquatic Chronic 4
H413
— H413
615-035-00-2
reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)
430-930-6
122886-55-9
Aquatic Chronic 4
H413
— H413
615-036-00-8
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)
430-940-0
— Aquatic Chronic 4
H413
— H413
615-037-00-3
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)
430-950-5
— Aquatic Chronic 4
H413
— H413
615-038-00-9
reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)
430-960-1
— Aquatic Chronic 4
H413
— H413
615-039-00-4
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)
430-970-4
— Aquatic Chronic 4
H413
— H413
615-044-00-1
4-chlorophenylisocyanate
203-176-9
104-12-1
Acute Tox. 2 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H335
H315
H318
H334
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H330
H302
H335
H315
H318
H334
H410
615-045-00-7
4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)
420-530-1
— Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Dgr
H334
H317
H413
616-107-00-6
cinidon ethyl (ISO);
ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate
— 142891-20-1
Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410
616-122-00-8
methylneodecanamide
414-460-9
105726-67-8
Acute Tox. 4 *
H302
GHS07
Wng
H302
616-126-00-X
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide
423-960-6
139756-01-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
616-131-00-7
1-aminocyclopentanecarboxamide
422-950-9
17193-28-1
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
H372**
H302
H318
GHS05
GHS08
GHS07
Dgr
H372**
H302
H318
616-136-00-4
reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)
430-380-7
— Aquatic Chronic 2
H411
GHS09
H411
616-137-00-X
4-dichloroacetyl-1-oxa-4-azaspiro[4,5]decane
401-130-4
71526-07-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-138-00-5
benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide
431-600-4
112226-61-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-139-00-0
(3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide
420-380-5
136465-81-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
616-140-00-6
N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]
429-380-1
133336-92-2
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-141-00-1
zoxamide (ISO);
(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide
— 156052-68-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10
616-144-00-8
3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-130-1
— Aquatic Chronic 4
H413
— H413
616-145-00-3
pethoxamide (ISO);
2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide
— 106700-29-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=100
616-146-00-9
N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide
431-330-7
142776-95-2
Aquatic Chronic 4
H413
— H413
616-147-00-4
1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide
424-160-1
139481-22-4
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-148-00-X
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide
424-550-1
84245-12-5
Carc. 1B
Muta. 1B
Repr. 1B
H350
H340
H360FD
GHS08
Dgr
H350
H340
H360FD
616-150-00-0
(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride
425-260-6
— STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H373**
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H373**
H318
H317
H411
616-151-00-6
N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide
425-650-6
171887-03-9
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
616-152-00-1
4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide
425-850-3
125971-96-2
Aquatic Chronic 4
H413
— H413
616-153-00-7
4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide
425-860-8
125971-57-5
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-154-00-2
3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-110-0
— Aquatic Chronic 4
H413
— H413
616-155-00-8
N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide
431-040-0
104560-40-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-156-00-3
6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide
430-500-8
204277-61-2
Aquatic Chronic 4
H413
— H413
616-157-00-9
3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride
427-780-9
114565-70-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
616-158-00-4
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide
427-880-2
90357-53-2
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411
616-160-00-5
2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]
429-090-3
61551-69-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
616-161-00-0
2,4-dichloro-5-hydroxyacetanilide
429-110-0
67669-19-6
Aquatic Chronic 3
H412
— H412
616-162-00-6
isostearic acid monoisopropanolamide
431-540-9
— Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
616-163-00-1
4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]
430-350-3
192463-88-0
Aquatic Chronic 4
H413
— H413
616-164-00-7
dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide
— 149961-52-4
Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d***
H332
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361d***
H332
H410
M=10
616-165-00-2
beflubutamid (ISO);
(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide
— 113614-08-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=100
616-166-00-8
cyazofamid (ISO);
4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide
— 120116-88-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=10
616-167-00-3
N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide
418-290-6
168612-06-4
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
616-168-00-9
1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium
418-440-0
136997-71-2
Skin Sens. 1
H317
GHS07
Wng
H317
616-169-00-4
4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one
420-220-4
92771-56-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-170-00-X
(2R)-2-amino-2-phenylacetamide
420-370-0
6485-67-2
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
616-171-00-5
2-(para-chlorophenyl)glycineamide
420-830-0
102333-75-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
616-172-00-0
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl
423-840-3
14691-89-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
616-174-00-1
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride
424-560-4
151257-01-1
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
616-175-00-7
2-(2-hexyldecyloxy)benzamide
431-230-3
202483-62-3
Aquatic Chronic 4
H413
— H413
616-176-00-2
3-N,N-bis(methoxyethyl)aminoacetanilide
432-530-7
24294-01-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-177-00-8
(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide
432-970-1
217324-98-6
Aquatic Chronic 4
H413
— H413
616-178-00-3
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide
434-500-9
52583-35-4
Aquatic Chronic 4
H413
— H413
616-179-00-9
2-chloro-N-(4-methylphenyl)acetamide
435-170-9
16634-82-5
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
616-180-00-4
N,N-(dimethylamino)thioacetamide hydrochloride
435-470-1
27366-72-9
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D***
H400
H410
GHS08
GHS09
Dgr
H360D***
H410
616-181-00-X
4'-methyldodecane-1-sulfonanilide
435-490-9
17417-32-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-182-00-5
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide
435-860-1
214417-91-1
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-183-00-0
N-dodecyl-4-methoxybenzamide
442-340-6
1854-15-5
Aquatic Chronic 4
H413
— H413
616-184-00-6
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide
442-560-2
105043-55-8
Aquatic Chronic 4
H413
— H413
616-186-00-7
N,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)
443-010-4
53641-10-4
Aquatic Chronic 3
H412
— H412
616-188-00-8
2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide
443-980-9
221215-20-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-189-00-3
N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide
444-780-4
452962-97-9
Aquatic Chronic 4
H413
— H413
616-190-00-9
N-decyl-4-nitrobenzamide
445-880-0
64026-19-3
Aquatic Chronic 4
H413
— H413
616-191-00-4
2-ethyl-N-methyl-N-(3-methylphenyl)butanamide
446-190-2
406488-30-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H319
H315
H317
H411
GHS07
GHS09
Wng
H302
H319
H315
H317
H411
616-192-00-X
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide
448-060-0
727678-39-9
Aquatic Chronic 4
H413
— H413
616-193-00-5
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide
449-940-7
368450-39-9
Aquatic Chronic 4
H413
— H413
616-194-00-0
2,2-diethoxy-N,N-dimethylacetamide
449-950-1
34640-92-1
Eye Irrit. 2
H319
GHS07
Wng
H319
616-196-00-1
disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide
419-990-4
— Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-197-00-7
reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;
N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide
422-500-1
— STOT RE 2 *
H373**
GHS08
Wng
H373**
616-198-00-2
1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene
423-300-7
— Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-200-00-1
reaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);
12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;
N,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)
432-430-3
— Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-201-00-7
12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine
432-840-2
220926-97-6
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
616-202-00-2
reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide
434-330-5
— Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Wng
H351
H317
H413
616-203-00-8
reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide
442-280-0
— Aquatic Chronic 4
H413
— H413
616-204-00-3
N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]
451-060-3
122886-55-9
Aquatic Chronic 4
H413
— H413
617-021-00-1
methylethylketone peroxide trimer
429-320-2
— Org. Perox. B****
Asp. Tox. 1
Skin Irrit. 2
Skin Sens. 1
H241
H304
H315
H317
GHS01
GHS02
GHS08
GHS07
Dgr
H241
H304
H315
H317
617-022-00-7
reaction mass of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate
442-480-8
— Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H242
H302
H314
H317
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H302
H314
H317
H411
647-017-00-5
laccase
420-150-4
80498-15-3
Resp. Sens. 1
H334
GHS08
Dgr
H334
Tekst urzędowy w EUR-Lex. Lexeva pokazuje treść przepisu, nie udziela porad prawnych. Moc prawną ma wyłącznie tekst opublikowany w Dzienniku Urzędowym Unii Europejskiej.